FORMULATION AND EVALUATION OF MEDICATED CHEWING GUM OF DOLASETRON AS AN ANTIEMETIC AGENT
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 4
Abstract
An attempt has been made to formulate new chewing gum for Dolasetron. The new drug delivery system was obtained, at room temperature conventional pharmaceutical equipment. The resulting chewing gum comprises a gum core combined with fillers, antioxidants, coloring agent and plasticizers, which provide smooth appearance and flexibility during storage and chewing. Drug release from a dosage form is the critical step in drug absorption and bioavailability, thus an experimental work has been designed to evaluate the efficiency of this kind of therapeutic system by verifying its capability to release the drug dose and by assessing the delivery of Dolasetron for bypassing the hepatic first pass effect. Simple diffusion into the medium causes the release of only a small percentage of the drug contained in the medicated chewing gum, while the delivery of the major part of the dose occurs during mastication. In the present study, an attempt has been made to formulate the chewing gum of Dolasetron. Different formulations of chewing gum with varying concentration of plasticizers like glycerol and castor oil were formulated. MCG II formulation was considered to be the best-optimized formula which consists of synthetic gum base (45%), Sorbitol (14.6%), sucrose (46%) etc. which shows first slow release the fast release in the phosphate buffer saline (ph 6.8). The cumulative drug release of MCG II formulation was found to be 99.43 %. From this study, we can conclude that the medicated chewing formulation can be a better choice in the coming years which provides several benefits and also benefits commercially.
Authors and Affiliations
Azra Shaikh
Keywords
Related Articles
- EP ID EP293860
- DOI -
- Views 76
- Downloads 0
OVARIECTOMISED AND LONG TERM INDUCED (OLI) RAT MODEL FOR PRECLINICAL ASSESSMENT OF OSTEOPOROTIC THERAPEUTICS.
Osteoporosis affects millions of people, especially the aged population and numerous researchers focus on developing novel pharmacotherapeutic agents for the prevention and treatment of osteoporosis. Animal models have b...
PREPARATION AND CHARACTERIZATION OF ISONIAZID CHITOSAN LOADED NANOPARTICLES
Although the part that we live in, is an age of creative technology and modernization, infectious diseases, like Tuberculosis (TB), still remain to be one of the greatest health challenges worldwide. The objective of thi...
Study on the biological safety of TiO2 nanoparticles based on the oxidative stress pathway
Objective: To study the effects of TiO2 nanoparticles in mice and explore the biological safety of TiO2 nanoparticles. Methods: The biological safety of TiO2 nanoparticles based on the oxidative stress pathway is investi...
FABRICATION AND CHARACTERIZATION OF NON STEROIDAL ANTI-INFLAMMATORY ALGINATE BEADS FOR SUSTAINED RELEASE USING NATURAL POLYMER
Extended release formulations are becoming more popular day by day for the delivery of non-steroidal anti-inflammatory drugs (NSAIDs) because of their ability to maintain optimal and therapeutically effective drug levels...
HEPATOPROTECTIVE ACTIVITY OF THE EXTRACT OF CRATAEVA NURVALA BARK AGAINST CCL4 INDUCED HEPATOTOXICITY IN RATS
The present work is focused on investigation of hepatoprotective activity of bark of Crataeva nurvala. It’s hepatoprotective activity was studied in the form of its aqueous and ethanolic extract and its isolated compound...